Helius Medical Technologies (HSDT) said Wednesday it received a Nasdaq hearings panel notice on Monday that the company has fulfilled compliance with the regulator's equity requirement for continued listing.
The company will be subject to a mandatory panel monitor for one year, effective immediately, Helius said.
Shares of the company were down 2.2% in recent Wednesday trading.
Price: 8.71, Change: -0.20, Percent Change: -2.24
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.